Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature Communications
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. nature communications
  3. articles
  4. article
Transcriptomic signature-guided depletion of intermediate alveolar epithelial cells ameliorates pulmonary fibrosis in mice
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 10 January 2026

Transcriptomic signature-guided depletion of intermediate alveolar epithelial cells ameliorates pulmonary fibrosis in mice

  • Fei Peng1 na1,
  • Chun-sun Jiang2 na1,
  • Zhen Zheng1 na1,
  • Shahram Aliyari3,
  • Dan Shan1,
  • Aaryan Sabharwal1,
  • Qinyan Yin1,
  • Shigeki Saito1,
  • Chao He4,
  • Ivan O. Rosas4,
  • Joseph A. Lasky1,
  • Victor J. Thannickal  ORCID: orcid.org/0000-0003-4266-86771 &
  • …
  • Yong Zhou  ORCID: orcid.org/0000-0003-3131-19121 

Nature Communications , Article number:  (2026) Cite this article

  • 2336 Accesses

  • 1 Altmetric

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Mechanisms of disease
  • Stem-cell differentiation

Abstract

Single-cell RNA sequencing (scRNA-seq) has identified intermediate epithelial states in pulmonary fibrosis, including KRT5-/KRT17+ aberrant basaloid cells in humans and Krt8+ alveolar differentiation intermediates (ADIs) in mice. Their functional contributions to fibrogenesis, however, remain unclear. Here, we introduce an RNA-sensing-dependent protein translation technology that enables selective targeting of Krt8+ ADI cells in vitro and in vivo. Transcriptomic analysis revealed Small Proline-Rich Protein 1 A (SPRR1A) mRNA as a shared marker of murine Krt8+ ADIs and human KRT5-/KRT17+ basaloid cells, distinguishing them from other lung cell populations. Using programmable RNA sensors, we demonstrated selective EGFP-labeling of Krt8+ ADI cells in vivo, which faithfully recapitulated their transcriptomic and phenotypic features. To test function, we developed an RNA-sensing-driven diphtheria toxin receptor (DTR) system for conditional ablation of Sprr1a+ cells. Targeted depletion markedly reduced fibrosis in bleomycin-injured mice, establishing transitional epithelial cells as pathogenic drivers and highlighting their potential as therapeutic targets in pulmonary fibrosis.

Similar content being viewed by others

Lung extracellular matrix modulates KRT5+ basal cell activity in pulmonary fibrosis

Article Open access 27 September 2023

Airway basal cells show a dedifferentiated KRT17highPhenotype and promote fibrosis in idiopathic pulmonary fibrosis

Article Open access 26 September 2022

Single-cell division tracing and transcriptomics reveal cell types and differentiation paths in the regenerating lung

Article Open access 12 March 2024

Data availability

The scRNA-seq data generated in this study have been deposited the Gene Expression Omnibus under accession code GSE311198. Source data are provided with this paper.

Code availability

Custom Python scripts used for the single-cell RNA-seq computational analyses have been deposited in a public GitHub repository and archived on Zenodo (https://doi.org/10.5281/zenodo.18027178). The scripts integrate existing open-source libraries to reproduce the analyses described in the previous section; no novel algorithms were developed.

References

  1. Basil, M. C., Alysandratos, K. D., Kotton, D. N. & Morrisey, E. E. Lung repair and regeneration: advanced models and insights into human disease. Cell Stem Cell 31, 439–454 (2024).

    Google Scholar 

  2. El Agha, E. & Thannickal, V. J. The lung mesenchyme in development, regeneration, and fibrosis. J. Clin. Investig. 133, e170498 (2023).

  3. Aspal, M. & Zemans, R. L. Mechanisms of ATII-to-ATI cell differentiation during lung regeneration. Int. J. Mol. Sci. 21, 3188 (2020).

  4. Beers, M. F. & Morrisey, E. E. The three R’s of lung health and disease: repair, remodeling, and regeneration. J. Clin. Investig. 121, 2065–2073 (2011).

    Google Scholar 

  5. Confalonieri, P. et al. Regeneration or repair? The role of alveolar epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis (IPF). Cells 11, 2095 (2022).

  6. Xie, T. et al. Abnormal respiratory progenitors in fibrotic lung injury. Stem Cell Res. Ther. 13, 64 (2022).

    Google Scholar 

  7. Lettieri, S. et al. The plastic interplay between lung regeneration phenomena and fibrotic evolution: current challenges and novel therapeutic perspectives. Int. J. Mol. Sci. 25, 547 (2023).

  8. Strunz, M. et al. Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis. Nat. Commun. 11, 3559 (2020).

    Google Scholar 

  9. Choi, J. et al. Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration. Cell Stem Cell 27, 366–382.e367 (2020).

    Google Scholar 

  10. Kobayashi, Y. et al. Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis. Nat. Cell Biol. 22, 934–946 (2020).

    Google Scholar 

  11. Habermann, A. C. et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Sci. Adv. 6, eaba1972 (2020).

    Google Scholar 

  12. Adams, T. S. et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci. Adv. 6, eaba1983 (2020).

    Google Scholar 

  13. Jiang, P. et al. Ineffectual type 2-to-Type 1 alveolar epithelial cell differentiation in idiopathic pulmonary fibrosis: persistence of the KRT8. Am. J. Respir. Crit. Care Med. 201, 1443–1447 (2020).

    Google Scholar 

  14. Sun, T. et al. TAZ is required for lung alveolar epithelial cell differentiation after injury. JCI Insight 5, e128674 (2019).

  15. Evans, K. V. & Lee, J. H. Alveolar wars: the rise of in vitro models to understand human lung alveolar maintenance, regeneration, and disease. Stem Cells Transl. Med. 9, 867–881 (2020).

    Google Scholar 

  16. Wu, H. et al. Progressive pulmonary fibrosis is caused by elevated mechanical tension on alveolar stem cells. Cell 180, 107–121 e117 (2020).

    Google Scholar 

  17. Yao, C. et al. Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 203, 707–717 (2021).

    Google Scholar 

  18. Finn, J. et al. Dlk1-mediated temporal regulation of notch signaling is required for differentiation of alveolar type II to type I cells during repair. Cell Rep. 26, 2942–2954.e2945 (2019).

    Google Scholar 

  19. Kathiriya, J. J. et al. Human alveolar type 2 epithelium transdifferentiates into metaplastic KRT5. Nat. Cell Biol. 24, 10–23 (2022).

    Google Scholar 

  20. Konkimalla, A. et al. Transitional cell states sculpt tissue topology during lung regeneration. Cell Stem Cell 30, 1486–1502.e1489 (2023).

    Google Scholar 

  21. Wang, F. et al. Regulation of epithelial transitional states in murine and human pulmonary fibrosis. J. Clin. Investig. 133, e165612 (2023).

  22. Qian, Y. et al. Programmable RNA sensing for cell monitoring and manipulation. Nature 610, 713–721 (2022).

    Google Scholar 

  23. Tan, M. H. et al. Dynamic landscape and regulation of RNA editing in mammals. Nature 550, 249–254 (2017).

    Google Scholar 

  24. Abudayyeh, O. O. et al. A cytosine deaminase for programmable single-base RNA editing. Science 365, 382–386 (2019).

    Google Scholar 

  25. Rauch, S. et al. Programmable RNA-guided RNA effector proteins built from human parts. Cell 178, 122–134.e112 (2019).

    Google Scholar 

  26. Limberis, M. P., Vandenberghe, L. H., Zhang, L., Pickles, R. J. & Wilson, J. M. Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol. Ther. 17, 294–301 (2009).

    Google Scholar 

  27. Strobel, B. et al. Modeling pulmonary disease pathways using recombinant adeno-associated virus 6.2. Am. J. Respir. Cell Mol. Biol. 53, 291–302 (2015).

    Google Scholar 

  28. van Lieshout, L. P. et al. A novel triple-mutant AAV6 capsid induces rapid and potent transgene expression in the muscle and respiratory tract of mice. Mol. Ther. Methods Clin. Dev. 9, 323–329 (2018).

    Google Scholar 

  29. Kang, M. H. et al. A lung tropic AAV vector improves survival in a mouse model of surfactant B deficiency. Nat. Commun. 11, 3929 (2020).

    Google Scholar 

  30. Kathiriya, J. J., Brumwell, A. N., Jackson, J. R., Tang, X. & Chapman, H. A. Distinct airway epithelial stem cells hide among club cells but mobilize to promote alveolar regeneration. Cell Stem Cell 26, 346–358.e344 (2020).

    Google Scholar 

  31. Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 179, 813–827 (2019).

    Google Scholar 

  32. Sharpless, N. E. & Sherr, C. J. Forging a signature of in vivo senescence. Nat. Rev. Cancer 15, 397–408 (2015).

    Google Scholar 

  33. Watanabe, S. et al. Resetting proteostasis with ISRIB promotes epithelial differentiation to attenuate pulmonary fibrosis. Proc. Nat. Acad. Sci. USA 118, e2101100118 (2021).

  34. Ting, C. et al. Biomarkers unveil insights into pathology of transitional epithelial states in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 210, 687–690 (2024).

    Google Scholar 

  35. Reyfman, P. A. et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 199, 1517–1536 (2019).

    Google Scholar 

  36. Ting, C. et al. Fatal COVID-19 and non-COVID-19 acute respiratory distress syndrome is associated with incomplete alveolar type 1 epithelial cell differentiation from the transitional state without fibrosis. Am. J. Pathol. 192, 454–467 (2021).

  37. Auyeung, V. C. et al. IRE1alpha drives lung epithelial progenitor dysfunction to establish a niche for pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 322, L564–L580 (2022).

    Google Scholar 

  38. Cervantes-Reyes, A., Smith, A. C., Chinigo, G. M., Blakemore, D. C. & Szostak, M. Decarbonylative Pd-catalyzed suzuki cross-coupling for the synthesis of structurally diverse heterobiaryls. Org. Lett. 24, 1678–1683 (2022).

    Google Scholar 

  39. Murphy, P. Z. & Jester, A. P. Pharmacists’ knowledge and perceptions of health literacy. J. Pharm. Pr. 36, 620–627 (2023).

    Google Scholar 

  40. Prasse, A. et al. BAL cell gene expression is indicative of outcome and airway basal cell involvement in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 199, 622–630 (2019).

    Google Scholar 

  41. Selman, M. & Pardo, A. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc. Am. Thorac. Soc. 3, 364–372 (2006).

    Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr. Jay K. Kolls and Dr. Kejing Song for their assistance with scRNA-seq. This work was supported in part by NIH grants HL139584, HL156973, and HL174994 (Y.Z.).

Author information

Author notes
  1. These authors contributed equally: Fei Peng, Chun-sun Jiang, Zhen Zheng.

Authors and Affiliations

  1. Section of Pulmonary Diseases, Critical Care and Environmental Medicine, John W. Deming Department of Medicine, Tulane University, New Orleans, LA, USA

    Fei Peng, Zhen Zheng, Dan Shan, Aaryan Sabharwal, Qinyan Yin, Shigeki Saito, Joseph A. Lasky, Victor J. Thannickal & Yong Zhou

  2. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

    Chun-sun Jiang

  3. Institute of Pathology Heidelberg, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany

    Shahram Aliyari

  4. Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA

    Chao He & Ivan O. Rosas

Authors
  1. Fei Peng
    View author publications

    Search author on:PubMed Google Scholar

  2. Chun-sun Jiang
    View author publications

    Search author on:PubMed Google Scholar

  3. Zhen Zheng
    View author publications

    Search author on:PubMed Google Scholar

  4. Shahram Aliyari
    View author publications

    Search author on:PubMed Google Scholar

  5. Dan Shan
    View author publications

    Search author on:PubMed Google Scholar

  6. Aaryan Sabharwal
    View author publications

    Search author on:PubMed Google Scholar

  7. Qinyan Yin
    View author publications

    Search author on:PubMed Google Scholar

  8. Shigeki Saito
    View author publications

    Search author on:PubMed Google Scholar

  9. Chao He
    View author publications

    Search author on:PubMed Google Scholar

  10. Ivan O. Rosas
    View author publications

    Search author on:PubMed Google Scholar

  11. Joseph A. Lasky
    View author publications

    Search author on:PubMed Google Scholar

  12. Victor J. Thannickal
    View author publications

    Search author on:PubMed Google Scholar

  13. Yong Zhou
    View author publications

    Search author on:PubMed Google Scholar

Contributions

F.P., C.J., Z.Z., and Y.Z. designed the study; F.P., C.J., Z.Z., D.S., A.S., and Y.Q., and C.H. performed experiments; F.P., C.J., Z.Z., S.A., and Y.Z. analyzed data; S.S., C.H., I.O.R., J.A.L., and V.J.T. participated in discussion; F.P., J.S., Z.Z., and Y.Z. wrote the manuscript.

Corresponding author

Correspondence to Yong Zhou.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Communications thanks Pinglong Xu, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Reporting summary

Transparent Peer Review file

Source data

Source data

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peng, F., Jiang, Cs., Zheng, Z. et al. Transcriptomic signature-guided depletion of intermediate alveolar epithelial cells ameliorates pulmonary fibrosis in mice. Nat Commun (2026). https://doi.org/10.1038/s41467-026-68354-y

Download citation

  • Received: 08 May 2025

  • Accepted: 05 January 2026

  • Published: 10 January 2026

  • DOI: https://doi.org/10.1038/s41467-026-68354-y

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Videos
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on Twitter
  • Sign up for alerts
  • RSS feed

About the journal

  • Aims & Scope
  • Editors
  • Journal Information
  • Open Access Fees and Funding
  • Calls for Papers
  • Editorial Values Statement
  • Journal Metrics
  • Editors' Highlights
  • Contact
  • Editorial policies
  • Top Articles

Publish with us

  • For authors
  • For Reviewers
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Nature Communications (Nat Commun)

ISSN 2041-1723 (online)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing